[HTML][HTML] Expanded carrier screening: a review of early implementation and literature

GA Lazarin, IS Haque - Seminars in perinatology, 2016 - Elsevier
… To address the pitfalls of incorporating severity into development of broad screening
programs, Lazarin et al. developed a classification algorithm that assigns severity (profound—4, …

Changing trends in carrier screening for genetic disease in the United States

SB Nazareth, GA Lazarin, JD Goldberg - Prenatal diagnosis, 2015 - Wiley Online Library
Genetic disease is the leading cause of infant death in the United States, accounting for
approximately 20% of annual infant mortality. Advances in genomic medicine and technological …

[HTML][HTML] An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals

GA Lazarin, IS Haque, S Nazareth, K Iori… - Genetics in …, 2013 - nature.com
Purpose: Recent developments in genomics have led to expanded carrier screening panels
capable of assessing hundreds of causal mutations for genetic disease. This new …

Modeled fetal risk of genetic diseases identified by expanded carrier screening

IS Haque, GA Lazarin, HP Kang, EA Evans… - Jama, 2016 - jamanetwork.com
… Drs Haque, Kang, Evans, Goldberg, and Mr Lazarin are employees of Counsyl, a laboratory
providing expanded carrier screening. Dr Wapner reported receiving grants paid to his …

Expanded carrier screening in the United States: a systematic evidence review exploring client and provider experiences

…, L Propst, C Mann, GA Lazarin… - Journal of Genetic …, 2022 - Wiley Online Library
The aim of carrier screening is to identify prospective parents at risk of having a pregnancy
affected with an autosomal recessive or X‐linked disorder. Though minimal guideline‐based …

[HTML][HTML] Systematic classification of disease severity for evaluation of expanded carrier screening panels

GA Lazarin, F Hawthorne, NS Collins, EA Platt… - PloS one, 2014 - journals.plos.org
Professional guidelines dictate that disease severity is a key criterion for carrier screening.
Expanded carrier screening, which tests for hundreds to thousands of mutations …

[HTML][HTML] Clinical utility of expanded carrier screening: results-guided actionability and outcomes

KAJ Taber, KA Beauchamp, GA Lazarin, D Muzzey… - Genetics in …, 2019 - Elsevier
… To compare actions among ARCs by disease severity, conditions were categorized by
severity according to the method described by Lazarin et al. For ARCs reporting that their …

Clinical utility of expanded carrier screening: reproductive behaviors of at‐risk couples

…, JD Goldberg, IS Haque, GA Lazarin… - Journal of genetic …, 2018 - Wiley Online Library
Expanded carrier screening (ECS) analyzes dozens or hundreds of recessive genes to
determine reproductive risk. Data on the clinical utility of screening conditions beyond …

[HTML][HTML] Systematic design and comparison of expanded carrier screening panels

…, HP Kang, EA Evans, JD Goldberg, GA Lazarin… - Genetics in …, 2018 - nature.com
Purpose The recent growth in pan-ethnic expanded carrier screening (ECS) has raised
questions about how such panels might be designed and evaluated systematically. Design …

Validation of a self-administrable, saliva-based RT-qPCR test detecting SARS-CoV-2

…, N Albanese, L Castillo, P Farinas, GA Lazarin… - MedRxiv, 2020 - medrxiv.org
Background Rapid and easy COVID-19 diagnostic testing is essential to controlling the
pandemic and facilitating safe resumption of clinical care, employment and other social activities. …